Xometry (NASDAQ:XMTR) Given New $30.00 Price Target at JPMorgan Chase & Co.

Xometry (NASDAQ:XMTR - Free Report) had its price target decreased by JPMorgan Chase & Co. from $45.00 to $30.00 in a research report released on Tuesday,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Several other equities research analysts have also commented on XMTR. Citigroup reduced their price target on shares of Xometry from $46.00 to $39.00 and set a "buy" rating for the company in a report on Thursday, February 27th. UBS Group boosted their price objective on shares of Xometry from $22.00 to $33.00 and gave the stock a "neutral" rating in a research note on Wednesday, February 26th. Royal Bank of Canada upped their target price on Xometry from $27.00 to $40.00 and gave the stock a "sector perform" rating in a report on Friday, January 3rd. JMP Securities reiterated a "market outperform" rating and issued a $42.00 price target on shares of Xometry in a report on Monday, February 10th. Finally, Cantor Fitzgerald upped their price objective on Xometry from $12.00 to $20.00 and gave the stock an "underweight" rating in a research note on Wednesday, February 26th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and six have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $34.44.

Xometry Stock Up 1.2 %

Shares of XMTR traded up $0.30 during midday trading on Tuesday, reaching $25.16. 353,308 shares of the stock were exchanged, compared to its average volume of 607,142. The company has a current ratio of 4.59, a quick ratio of 4.55 and a debt-to-equity ratio of 0.90. The company's 50 day moving average is $24.90 and its two-hundred day moving average is $29.61. The company has a market capitalization of $1.27 billion, a P/E ratio of -23.96 and a beta of 0.72. Xometry has a 52 week low of $11.08 and a 52 week high of $45.33.

Insider Buying and Selling at Xometry

In other Xometry news, COO Peter Goguen sold 3,000 shares of Xometry stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $35.57, for a total transaction of $106,710.00. Following the completion of the sale, the chief operating officer now owns 161,993 shares of the company's stock, valued at approximately $5,762,091.01. The trade was a 1.82 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Randolph Altschuler sold 27,566 shares of the business's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $26.60, for a total value of $733,255.60. Following the sale, the chief executive officer now owns 256,570 shares in the company, valued at approximately $6,824,762. The trade was a 9.70 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 78,256 shares of company stock worth $2,012,889. 16.79% of the stock is owned by insiders.

Institutional Investors Weigh In On Xometry

A number of institutional investors and hedge funds have recently modified their holdings of the company. Palumbo Wealth Management LLC raised its position in Xometry by 40.8% during the 1st quarter. Palumbo Wealth Management LLC now owns 14,263 shares of the company's stock worth $355,000 after buying an additional 4,133 shares during the last quarter. SG Americas Securities LLC boosted its holdings in shares of Xometry by 259.0% in the 1st quarter. SG Americas Securities LLC now owns 50,035 shares of the company's stock valued at $1,247,000 after acquiring an additional 36,097 shares during the last quarter. GAMMA Investing LLC increased its stake in shares of Xometry by 160.1% in the first quarter. GAMMA Investing LLC now owns 1,004 shares of the company's stock worth $25,000 after acquiring an additional 618 shares during the period. OLD National Bancorp IN purchased a new position in shares of Xometry during the first quarter worth $1,415,000. Finally, Rhumbline Advisers lifted its position in Xometry by 2.2% during the first quarter. Rhumbline Advisers now owns 60,682 shares of the company's stock valued at $1,512,000 after purchasing an additional 1,315 shares during the period. Institutional investors and hedge funds own 97.31% of the company's stock.

About Xometry

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.